Latest News about MNMD
Recent news which mentions MNMD
MindMed Completes Phase 1 Clinical Trial Of Non-Hallucinogenic Proprietary Derivative Of Ibogaine
January 04, 2022
Tickers
MNMD
From Benzinga
2021 Was The Year Psychedelics Conquered Capitalism...Or Is It The Other Way Around?
December 30, 2021
From Benzinga
Cannabis Movers & Shakers: MindMed & Trulieve Management Shake-Ups, Credex Corp & CapStone Bolster Leadership Teams
December 29, 2021
From Benzinga
MindMed Shares Update On Phase 2b Trials of LSD For Treating Generalized Anxiety Disorder
December 22, 2021
Tickers
MNMD
From Benzinga
MNMD Stock: The Latest Psychedelic Drug News MindMed Fans Should Watch
December 21, 2021
Tickers
MNMD
From InvestorPlace
MindMed Advances Phase 2a LSD Microdose Trial For Adult ADHD
December 17, 2021
Tickers
MNMD
From Benzinga
Mind Medicine to Study Effect of Time on LSD Microdosing
December 17, 2021
From Benzinga
Cannabis Movers & Shakers: HEXO, Agrify, MindMed, KetamineOne
December 15, 2021
From Benzinga
From Benzinga
Trip to Sustainability? This Company Is Developing Synthetic Psychedelics To Attempt to Fight Mental Illness
December 13, 2021
From Benzinga
Fintech Focus For December 13, 2021
December 12, 2021
From Benzinga
From Benzinga
Psilera's DMT-Derived Drug Sees Positive Results in Pre-Clinical Study
December 09, 2021
From Benzinga
FDA Shows Support For Development Of MindMed's Session Monitoring System
December 09, 2021
Tickers
MNMD
From Benzinga
This Company Is Making Synthetic Psychedelics With a Goal To Combat Mental Illness
December 08, 2021
From Benzinga
MNMD Stock Pops Higher After MindMed Unveils ‘Psychedelic’ Data
December 01, 2021
Tickers
MNMD
From InvestorPlace
Antidepressants Can Be Used During Psilocybin Treatment, A New MindMed & Liechti Lab Study Finds
November 30, 2021
Tickers
MNMD
From Benzinga
3 Psychedelic Stocks for Potential Out-of-This-World Gains
November 18, 2021
From InvestorPlace
MindMed Q3 Earnings: Big Improvement, Kicks Off Sleep & Cognitive Study With Dose Low-Dose LSD
November 16, 2021
Tickers
MNMD
From Benzinga
Cannabis Movers & Shakers: Mind Medicine, Avant Brands, Delic, Agrify, Ascend Wellness, Pure Beauty
November 11, 2021
From Benzinga
From InvestorPlace
How This Company Is Using Psychedelic Medicines and Therapies to Treat Addiction and Mental Illness
November 02, 2021
From Benzinga
From Benzinga
Psyched: MindMed's MDMA Program For Autism, Small Pharma's New Patent, NovaMentis' Orphan Drug Designation
November 01, 2021
From Benzinga
Biotech Companies Are Embracing the Growing Psychedelic Drug Market To Confront a Global Increase in Depression and Anxiety
October 27, 2021
From Benzinga
These 4 Psychedelic Biotech Stocks Are Leading the Pack
October 26, 2021
From Motley Fool
Phase 2 Trial On Ayahuasca's Active Ingredient Puts Small Pharma On Track To Winning The Psychedelics Race
October 20, 2021
From Benzinga
7 Penny Stocks to Buy – While They’re Still Penny Stocks
October 19, 2021
From InvestorPlace
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
October 18, 2021
From Benzinga
3 Penny Stocks Waiting on FDA Approval for Rocket Fuel
October 18, 2021
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
